Telpinstar Tablet 80/5 mg

Adult dose

The recommended dose of this medication is 1 tablet once daily, to be taken with water regardless of meals. It is recommended to take it at the same time every day if possible (e.g., in the morning). In patients with severe renal impairment, treatment should start at a lower dose, and the dose should be gradually increased. In patients with mild or moderate liver impairment, the daily dosage of telmisartan should not exceed 40 mg.

Child dose

Safety and efficacy have not been established in pediatric patients under 18 years of age, so the administration of this medication is not recommended.

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. If this medication is taken during pregnancy, it should be discontinued as soon as possible, and if necessary, replaced with another safe medication. This medication should not be administered to patients with certain diseases, such as those with severe liver or heart conditions, women of childbearing potential, or nursing mothers. Additionally, caution is needed when using this medication in specific patient groups, such as patients with impaired liver function, kidney disease, the elderly, and patients with heart valve disease. Side effects such as dizziness and peripheral edema may occur when taking this medication, so consult a healthcare professional if any unusual symptoms arise. Symptoms of hypotension may occur, so if symptoms are present, lie down immediately and seek treatment at a hospital if necessary. This medication can cause hyperkalemia, so potassium levels in the blood should be monitored regularly. Patients with decreased kidney function should periodically check kidney function and electrolyte levels while taking this medication. This medication can interact with other drugs, so inform your healthcare provider of any other medications you are taking, especially lithium, digoxin, warfarin, and non-steroidal anti-inflammatory drugs. It is advisable not to use this medication while breastfeeding, and caution should be exercised when driving or operating machinery as dizziness or drowsiness may occur. In case of overdose, symptoms such as hypotension, dizziness, and heart abnormalities may occur, so compliance with the prescribed dosage is crucial, and if any unusual symptoms arise, visit a medical facility immediately. Safety and efficacy have not been adequately established in pediatric patients, so this medication is not recommended for children. This medication should be stored out of the reach of children and taken out of the sealed packaging immediately before use.

Serious side effects

Urticaria, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blistering, skin peeling, pain in mouth/eye mucosa, severe skin reactions, shortness of breath or difficulty breathing, asthma attack, respiratory distress with cough and fever, yellowing of skin or eyes (jaundice), extreme fatigue throughout the body, liver abnormalities (jaundice), sudden and severe headache, thunderclap headache

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory tract infection
• urinary tract infection
• cystitis
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia
• hyperglycemia

This medication is sensitive to light, so it should be stored in a container that does not allow light in, and should be kept at room temperature between 1 degree and 30 degrees. Storing it this way helps maintain the medication's effectiveness and prevent degradation.

Appearance

Biconvex oval double layer tablet in white and light blue color

Package unit

Tablet/PTP - 30 tablets/PTP [(10 tablets/PTP × 3)]